Citations

Citations to this article as recorded by  

• Pancreatoblastoma with a novel fusion gene ofIQSEC1‐RAF1
  Hironori Goto, Yuhki Koga, Kenichi Kohashi, Hiroaki Ono, Junkichi Takemoto, Toshiharu Matsuura, Tatsuro Tajiri, Kenji Ihara, Yoshinao Oda, Shouichi Ohga
  Pediatric Blood & Cancer.2023;[Epub]     CrossRef
• Imaging phenotype using 18F-fluorodeoxyglucose positron emission tomography–based radiomics and genetic alterations of pancreatic ductal adenocarcinoma
  Chae Hong Lim, Young Seok Cho, Joon Young Choi, Kyung-Han Lee, Jong Kyun Lee, Ji Hye Min, Seung Hyup Hyun
  European Journal of Nuclear Medicine and Molecular Imaging.2020; 47(9): 2113.     CrossRef
• NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS
  Mitali Chattopadhyay, Ravinder Kodela, Gabriela Santiago, Thuy Tien C. Le, Niharika Nath, Khosrow Kashfi
  Biochemical Pharmacology.2020; 176: 113857.     CrossRef
• Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
  Friederike Inga Nollmann, Dietrich Alexander Ruess
  Biomedicines.2020; 8(8): 281.     CrossRef
• Ancillary Techniques in Cytologic Specimens Obtained from Solid Lesions of the Pancreas: A Review
  Jonas J. Heymann, Momin T. Siddiqui
  Acta Cytologica.2020; 64(1-2): 103.     CrossRef
• DNA polymerase η mutational signatures are found in a variety of different types of cancer
  Igor B. Rogozin, Alexander Goncearenco, Artem G. Lada, Subhajyoti De, Vyacheslav Yurchenko, German Nudelman, Anna R. Panchenko, David N. Cooper, Youri I. Pavlov
  Cell Cycle.2018; 17(3): 348.     CrossRef
• Genetics of Pancreatic Neoplasms and Role of Screening
  Venkata S. Katabathina, Omid Y. Rikhtehgar, Anil K. Dasyam, Rohan Manickam, Srinivasa R. Prasad
  Magnetic Resonance Imaging Clinics of North America.2018; 26(3): 375.     CrossRef
• Team work and cytopathology molecular diagnosis of solid pancreatic lesions
  Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario de
  Digestive Endoscopy.2017; 29(6): 657.     CrossRef
• Mutational signatures and mutable motifs in cancer genomes
  Igor B. Rogozin, Youri I. Pavlov, Alexander Goncearenco, Subhajyoti De, Artem G. Lada, Eugenia Poliakov, Anna R. Panchenko, David N. Cooper
  Briefings in Bioinformatics.2017;[Epub]     CrossRef
• The evolving field of genomic biomarkers to characterize pancreatic cystic neoplasia by EUS-guided FNA
  Ferga C. Gleeson, Michael J. Levy
  Gastrointestinal Endoscopy.2016; 83(1): 149.     CrossRef
• MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors
  Rui Gradiz, Henriqueta C. Silva, Lina Carvalho, Maria Filomena Botelho, Anabela Mota-Pinto
  Scientific Reports.2016;[Epub]     CrossRef
• p53 and p16/p19 Loss Promotes Different Pancreatic Tumor Types from PyMT-Expressing Progenitor Cells
  Stephanie Azzopardi, Sharon Pang, David S. Klimstra, Yi-Chieh Nancy Du
  Neoplasia.2016; 18(10): 610.     CrossRef
• MicroRNA-506 participates in pancreatic cancer pathogenesis by targeting PIM3
  JUNDONG DU, XI ZHENG, SHOUWANG CAI, ZIMAN ZHU, JINGWANG TAN, BIN HU, ZHIQIANG HUANG, HUABO JIAO
  Molecular Medicine Reports.2015; 12(4): 5121.     CrossRef